sacituzumab govitecan
Term · Oncology and biomedicine · MLC-T-ONC-007532
A drug used to treat adults with certain types of breast cancer that have already been treated with other therapy. It is also being studied in the treatment of other types of cancer. Sacituzumab govitecan contains a monoclonal antibody called sacituzumab that binds to a protein called TROP2, which is found on some cancer cells. It also contains an anticancer drug called SN-38, which may help kill cancer cells. Sacituzumab govitecan is a type of antibody-drug conjugate. Also called Trodelvy.
| Identifier | MLC-T-ONC-007532 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Trodelvy |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007532",
"term": "sacituzumab govitecan",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with certain types of breast cancer that have already been treated with other therapy. It is also being studied in the treatment of other types of cancer. Sacituzumab govitecan contains a monoclonal antibody called sacituzumab that binds to a protein called TROP2, which is found on some cancer cells. It also contains an anticancer drug called SN-38, which may help kill cancer cells. Sacituzumab govitecan is a type of antibody-drug conjugate. Also called Trodelvy.",
"synonyms": [
"Trodelvy"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/sacituzumab-govitecan/"
}
Record 14,638 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.